An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

Running, not enrolling · Early Phase 1

Conditions studied: Prostate Carcinoma

In brief

This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.

Key facts

Study ID

NCT05047965

Run by

M.D. Anderson Cancer Center

People needed

65

Starts

2013-04-25

Expected to finish

2027-02-02

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy proven prostate cancer patients who are scheduled to undergo prostatectomy.
• Patient who is scheduled to have a clinically indicated staging endorectal prostate MRI exam.
• Patients who have signed their informed consent form to undergo the study.

You may not qualify if…

• Known prior hormone ablation or radiation therapy (pelvic or prostate).
• Patients who do not want to undergo prostatectomy and prefer other therapy or surveillance.
• Contraindication to conventional MR imaging (e. g. metal implants, pace maker, etc.).

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.